National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 1236188

History of Changes from the VAERS Wayback Machine

First Appeared on 4/23/2021

VAERS ID: 1236188
VAERS Form:2
Age:
Sex:Female
Location:Arizona
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted:0000-00-00
Entered:2021-04-21
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN 1805020 / UNK - / -

Administered by: Other      Purchased by: ??
Symptoms: Hypoaesthesia, Injection site mass, Injection site discomfort

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: XARELTO
Current Illness: Factor V Leiden mutation
Preexisting Conditions: Comments: Unknown
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': USJNJFOC20210427631

Write-up: LUMP AT THE INJECTION SITE (QUARTER SIZE OR BIGGER LUMP); DISCOMFORT AT INJECTION SITE; ARM/HAND NUMBNESS; This spontaneous report received from a patient concerned a female of unspecified age. The patient''s height, and weight were not reported. The patient''s concurrent conditions included factor v leiden mutation. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805020, expiry: UNKNOWN) dose was not reported, administered on 22-MAR-2021 for prophylactic vaccination. Concomitant medications included rivaroxaban for pulmonary embolism bilateral lungs, and deep vein thrombosis right side. On an unspecified date, the subject experienced lump at the injection site (quarter size or bigger lump), discomfort at injection site, and arm/hand numbness. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the lump at the injection site (quarter size or bigger lump), discomfort at injection site and arm/hand numbness was not reported. This report was non-serious.


Changed on 5/7/2021

VAERS ID: 1236188 Before After
VAERS Form:2
Age:
Sex:Female
Location:Arizona
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted:0000-00-00
Entered:2021-04-21
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN 1805020 / UNK - / -

Administered by: Other      Purchased by: ??
Symptoms: Hypoaesthesia, Injection site mass, Injection site discomfort

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: XARELTO
Current Illness: Factor V Leiden mutation
Preexisting Conditions: Comments: Unknown
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': USJNJFOC20210427631

Write-up: LUMP AT THE INJECTION SITE (QUARTER SIZE OR BIGGER LUMP); DISCOMFORT AT INJECTION SITE; ARM/HAND NUMBNESS; This spontaneous report received from a patient concerned a female of unspecified age. The patient''s height, and weight were not reported. The patient''s concurrent conditions included factor v leiden mutation. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805020, expiry: UNKNOWN) dose was not reported, administered on 22-MAR-2021 for prophylactic vaccination. Concomitant medications included rivaroxaban for pulmonary embolism bilateral lungs, and deep vein thrombosis right side. On an unspecified date, the subject experienced lump at the injection site (quarter size or bigger lump), discomfort at injection site, and arm/hand numbness. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the lump at the injection site (quarter size or bigger lump), discomfort at injection site and arm/hand numbness was not reported. This report was non-serious.


Changed on 5/14/2021

VAERS ID: 1236188 Before After
VAERS Form:2
Age:
Sex:Female
Location:Arizona
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted:0000-00-00
Entered:2021-04-21
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN 1805020 / UNK - / -

Administered by: Other      Purchased by: ??
Symptoms: Hypoaesthesia, Injection site mass, Injection site discomfort

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: XARELTO
Current Illness: Factor V Leiden mutation
Preexisting Conditions: Comments: Unknown
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': USJNJFOC20210427631

Write-up: LUMP AT THE INJECTION SITE (QUARTER SIZE OR BIGGER LUMP); DISCOMFORT AT INJECTION SITE; ARM/HAND NUMBNESS; This spontaneous report received from a patient concerned a female of unspecified age. The patient''s height, and weight were not reported. The patient''s concurrent conditions included factor v leiden mutation. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805020, expiry: UNKNOWN) dose was not reported, administered on 22-MAR-2021 for prophylactic vaccination. Concomitant medications included rivaroxaban for pulmonary embolism bilateral lungs, and deep vein thrombosis right side. On an unspecified date, the subject experienced lump at the injection site (quarter size or bigger lump), discomfort at injection site, and arm/hand numbness. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the lump at the injection site (quarter size or bigger lump), discomfort at injection site and arm/hand numbness was not reported. This report was non-serious.

New Search

Link To This Search Result:

https://medalerts.org/vaersdb/findfield.php?IDNUMBER=1236188&WAYBACKHISTORY=ON

Government Disclaimer on use of this data


Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166